3.23.1 html 122 262 1 false 47 0 false 8 false false R1.htm 0000001 - Document - Cover Page Sheet http://www.ovidrx.com/role/CoverPage Cover Page Cover 1 false false R2.htm 0000002 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.ovidrx.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 0000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.ovidrx.com/role/CondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 0000004 - Statement - Condensed Consolidated Statements of Operations Sheet http://www.ovidrx.com/role/CondensedConsolidatedStatementsofOperations Condensed Consolidated Statements of Operations Statements 4 false false R5.htm 0000005 - Statement - Condensed Consolidated Statements of Comprehensive Loss Sheet http://www.ovidrx.com/role/CondensedConsolidatedStatementsofComprehensiveLoss Condensed Consolidated Statements of Comprehensive Loss Statements 5 false false R6.htm 0000006 - Statement - Condensed Consolidated Statements of Stockholders' Equity Sheet http://www.ovidrx.com/role/CondensedConsolidatedStatementsofStockholdersEquity Condensed Consolidated Statements of Stockholders' Equity Statements 6 false false R7.htm 0000007 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.ovidrx.com/role/CondensedConsolidatedStatementsofCashFlows Condensed Consolidated Statements of Cash Flows Statements 7 false false R8.htm 0000008 - Disclosure - NATURE OF OPERATIONS Sheet http://www.ovidrx.com/role/NATUREOFOPERATIONS NATURE OF OPERATIONS Notes 8 false false R9.htm 0000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.ovidrx.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 9 false false R10.htm 0000010 - Disclosure - CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES Sheet http://www.ovidrx.com/role/CASHCASHEQUIVALENTSANDMARKETABLESECURITIES CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES Notes 10 false false R11.htm 0000011 - Disclosure - PROPERTY AND EQUIPMENT AND INTANGIBLE ASSETS Sheet http://www.ovidrx.com/role/PROPERTYANDEQUIPMENTANDINTANGIBLEASSETS PROPERTY AND EQUIPMENT AND INTANGIBLE ASSETS Notes 11 false false R12.htm 0000012 - Disclosure - LEASES Sheet http://www.ovidrx.com/role/LEASES LEASES Notes 12 false false R13.htm 0000013 - Disclosure - ACCRUED EXPENSES Sheet http://www.ovidrx.com/role/ACCRUEDEXPENSES ACCRUED EXPENSES Notes 13 false false R14.htm 0000014 - Disclosure - STOCKHOLDERS??? EQUITY Sheet http://www.ovidrx.com/role/STOCKHOLDERSEQUITY STOCKHOLDERS??? EQUITY Notes 14 false false R15.htm 0000015 - Disclosure - STOCK-BASED COMPENSATION Sheet http://www.ovidrx.com/role/STOCKBASEDCOMPENSATION STOCK-BASED COMPENSATION Notes 15 false false R16.htm 0000016 - Disclosure - INCOME TAXES Sheet http://www.ovidrx.com/role/INCOMETAXES INCOME TAXES Notes 16 false false R17.htm 0000017 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://www.ovidrx.com/role/COMMITMENTSANDCONTINGENCIES COMMITMENTS AND CONTINGENCIES Notes 17 false false R18.htm 0000018 - Disclosure - COLLABORATION AND LICENSE AGREEMENTS Sheet http://www.ovidrx.com/role/COLLABORATIONANDLICENSEAGREEMENTS COLLABORATION AND LICENSE AGREEMENTS Notes 18 false false R19.htm 0000019 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://www.ovidrx.com/role/RELATEDPARTYTRANSACTIONS RELATED PARTY TRANSACTIONS Notes 19 false false R20.htm 0000020 - Disclosure - NET LOSS PER SHARE Sheet http://www.ovidrx.com/role/NETLOSSPERSHARE NET LOSS PER SHARE Notes 20 false false R21.htm 0000021 - Disclosure - SUBSEQUENT EVENT Sheet http://www.ovidrx.com/role/SUBSEQUENTEVENT SUBSEQUENT EVENT Notes 21 false false R22.htm 0000022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.ovidrx.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 22 false false R23.htm 0000023 - Disclosure - CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES (Tables) Sheet http://www.ovidrx.com/role/CASHCASHEQUIVALENTSANDMARKETABLESECURITIESTables CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES (Tables) Tables http://www.ovidrx.com/role/CASHCASHEQUIVALENTSANDMARKETABLESECURITIES 23 false false R24.htm 0000024 - Disclosure - PROPERTY AND EQUIPMENT AND INTANGIBLE ASSETS (Tables) Sheet http://www.ovidrx.com/role/PROPERTYANDEQUIPMENTANDINTANGIBLEASSETSTables PROPERTY AND EQUIPMENT AND INTANGIBLE ASSETS (Tables) Tables http://www.ovidrx.com/role/PROPERTYANDEQUIPMENTANDINTANGIBLEASSETS 24 false false R25.htm 0000025 - Disclosure - LEASES (Tables) Sheet http://www.ovidrx.com/role/LEASESTables LEASES (Tables) Tables http://www.ovidrx.com/role/LEASES 25 false false R26.htm 0000026 - Disclosure - ACCRUED EXPENSES (Tables) Sheet http://www.ovidrx.com/role/ACCRUEDEXPENSESTables ACCRUED EXPENSES (Tables) Tables http://www.ovidrx.com/role/ACCRUEDEXPENSES 26 false false R27.htm 0000027 - Disclosure - STOCK-BASED COMPENSATION (Tables) Sheet http://www.ovidrx.com/role/STOCKBASEDCOMPENSATIONTables STOCK-BASED COMPENSATION (Tables) Tables http://www.ovidrx.com/role/STOCKBASEDCOMPENSATION 27 false false R28.htm 0000028 - Disclosure - NET LOSS PER SHARE (Tables) Sheet http://www.ovidrx.com/role/NETLOSSPERSHARETables NET LOSS PER SHARE (Tables) Tables http://www.ovidrx.com/role/NETLOSSPERSHARE 28 false false R29.htm 0000029 - Disclosure - NATURE OF OPERATIONS - Additional Information (Detail) Sheet http://www.ovidrx.com/role/NATUREOFOPERATIONSAdditionalInformationDetail NATURE OF OPERATIONS - Additional Information (Detail) Details 29 false false R30.htm 0000030 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Detail) Sheet http://www.ovidrx.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetail SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Detail) Details 30 false false R31.htm 0000031 - Disclosure - CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES - Summary of Fair Value of Cash and Cash Equivalents and Gross Unrealized Holding Gains and Losses (Detail) Sheet http://www.ovidrx.com/role/CASHCASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofFairValueofCashandCashEquivalentsandGrossUnrealizedHoldingGainsandLossesDetail CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES - Summary of Fair Value of Cash and Cash Equivalents and Gross Unrealized Holding Gains and Losses (Detail) Details 31 false false R32.htm 0000032 - Disclosure - CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES - Additional Information (Detail) Sheet http://www.ovidrx.com/role/CASHCASHEQUIVALENTSANDMARKETABLESECURITIESAdditionalInformationDetail CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES - Additional Information (Detail) Details 32 false false R33.htm 0000033 - Disclosure - PROPERTY AND EQUIPMENT AND INTANGIBLE ASSETS - Summary of Property and Equipment (Detail) Sheet http://www.ovidrx.com/role/PROPERTYANDEQUIPMENTANDINTANGIBLEASSETSSummaryofPropertyandEquipmentDetail PROPERTY AND EQUIPMENT AND INTANGIBLE ASSETS - Summary of Property and Equipment (Detail) Details 33 false false R34.htm 0000034 - Disclosure - PROPERTY AND EQUIPMENT AND INTANGIBLE ASSETS - Additional Information (Detail) Sheet http://www.ovidrx.com/role/PROPERTYANDEQUIPMENTANDINTANGIBLEASSETSAdditionalInformationDetail PROPERTY AND EQUIPMENT AND INTANGIBLE ASSETS - Additional Information (Detail) Details 34 false false R35.htm 0000035 - Disclosure - LEASES - Additional Information (Detail) Sheet http://www.ovidrx.com/role/LEASESAdditionalInformationDetail LEASES - Additional Information (Detail) Details 35 false false R36.htm 0000036 - Disclosure - LEASES - Schedule of ROU Asset and Lease Liabilities Related to the Company Operating Lease (Detail) Sheet http://www.ovidrx.com/role/LEASESScheduleofROUAssetandLeaseLiabilitiesRelatedtotheCompanyOperatingLeaseDetail LEASES - Schedule of ROU Asset and Lease Liabilities Related to the Company Operating Lease (Detail) Details 36 false false R37.htm 0000037 - Disclosure - LEASES - Schedule of Components of Operating Lease Cost (Detail) Sheet http://www.ovidrx.com/role/LEASESScheduleofComponentsofOperatingLeaseCostDetail LEASES - Schedule of Components of Operating Lease Cost (Detail) Details 37 false false R38.htm 0000038 - Disclosure - LEASES - Schedule of Future Minimum Commitments Under Under the Non-Cancelable Operating Lease (Detail) Sheet http://www.ovidrx.com/role/LEASESScheduleofFutureMinimumCommitmentsUnderUndertheNonCancelableOperatingLeaseDetail LEASES - Schedule of Future Minimum Commitments Under Under the Non-Cancelable Operating Lease (Detail) Details 38 false false R39.htm 0000039 - Disclosure - ACCRUED EXPENSES - Schedule of Accrued Expenses (Detail) Sheet http://www.ovidrx.com/role/ACCRUEDEXPENSESScheduleofAccruedExpensesDetail ACCRUED EXPENSES - Schedule of Accrued Expenses (Detail) Details 39 false false R40.htm 0000040 - Disclosure - STOCKHOLDERS??? EQUITY - Additional Information (Detail) Sheet http://www.ovidrx.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetail STOCKHOLDERS??? EQUITY - Additional Information (Detail) Details 40 false false R41.htm 0000041 - Disclosure - STOCK-BASED COMPENSATION - Additional Information (Detail) Sheet http://www.ovidrx.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetail STOCK-BASED COMPENSATION - Additional Information (Detail) Details 41 false false R42.htm 0000042 - Disclosure - STOCK-BASED COMPENSATION - Schedule of Recognized Stock-Based Compensation Expense (Detail) Sheet http://www.ovidrx.com/role/STOCKBASEDCOMPENSATIONScheduleofRecognizedStockBasedCompensationExpenseDetail STOCK-BASED COMPENSATION - Schedule of Recognized Stock-Based Compensation Expense (Detail) Details 42 false false R43.htm 0000043 - Disclosure - STOCK-BASED COMPENSATION - Schedule of Allocation of Stock-Based Compensation Expense by Plan (Detail) Sheet http://www.ovidrx.com/role/STOCKBASEDCOMPENSATIONScheduleofAllocationofStockBasedCompensationExpensebyPlanDetail STOCK-BASED COMPENSATION - Schedule of Allocation of Stock-Based Compensation Expense by Plan (Detail) Details 43 false false R44.htm 0000044 - Disclosure - STOCK-BASED COMPENSATION - Summary of Assumptions Used to Compute Fair Value of Options Granted (Detail) Sheet http://www.ovidrx.com/role/STOCKBASEDCOMPENSATIONSummaryofAssumptionsUsedtoComputeFairValueofOptionsGrantedDetail STOCK-BASED COMPENSATION - Summary of Assumptions Used to Compute Fair Value of Options Granted (Detail) Details 44 false false R45.htm 0000045 - Disclosure - STOCK-BASED COMPENSATION - Summary of Options Outstanding and Weighted Average Exercise Price (Detail) Sheet http://www.ovidrx.com/role/STOCKBASEDCOMPENSATIONSummaryofOptionsOutstandingandWeightedAverageExercisePriceDetail STOCK-BASED COMPENSATION - Summary of Options Outstanding and Weighted Average Exercise Price (Detail) Details 45 false false R46.htm 0000046 - Disclosure - INCOME TAXES - Additional Information (Detail) Sheet http://www.ovidrx.com/role/INCOMETAXESAdditionalInformationDetail INCOME TAXES - Additional Information (Detail) Details 46 false false R47.htm 0000047 - Disclosure - COMMITMENTS AND CONTINGENCIES - Additional Information (Detail) Sheet http://www.ovidrx.com/role/COMMITMENTSANDCONTINGENCIESAdditionalInformationDetail COMMITMENTS AND CONTINGENCIES - Additional Information (Detail) Details 47 false false R48.htm 0000048 - Disclosure - COLLABORATION AND LICENSE AGREEMENTS - Additional Information (Detail) Sheet http://www.ovidrx.com/role/COLLABORATIONANDLICENSEAGREEMENTSAdditionalInformationDetail COLLABORATION AND LICENSE AGREEMENTS - Additional Information (Detail) Details 48 false false R49.htm 0000049 - Disclosure - NET LOSS PER SHARE - Summary of Calculation of Basic and Diluted Earnings (Loss) per Share (Details) Sheet http://www.ovidrx.com/role/NETLOSSPERSHARESummaryofCalculationofBasicandDilutedEarningsLossperShareDetails NET LOSS PER SHARE - Summary of Calculation of Basic and Diluted Earnings (Loss) per Share (Details) Details 49 false false R50.htm 0000050 - Disclosure - NET LOSS PER SHARE - Schedule of Potentially Dilutive Securities Excluded from Computations of Diluted Weighted Average Shares Outstanding (Detail) Sheet http://www.ovidrx.com/role/NETLOSSPERSHAREScheduleofPotentiallyDilutiveSecuritiesExcludedfromComputationsofDilutedWeightedAverageSharesOutstandingDetail NET LOSS PER SHARE - Schedule of Potentially Dilutive Securities Excluded from Computations of Diluted Weighted Average Shares Outstanding (Detail) Details 50 false false R51.htm 0000051 - Disclosure - SUBSEQUENT EVENT (Details) Sheet http://www.ovidrx.com/role/SUBSEQUENTEVENTDetails SUBSEQUENT EVENT (Details) Details http://www.ovidrx.com/role/SUBSEQUENTEVENT 51 false false All Reports Book All Reports [dq-0542-Deprecated-Concept] Concept RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty in us-gaap/2022 used in 1 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. ovid-20230331.htm 4 ovid-20230331.htm ovid-20230331.xsd ovid-20230331_cal.xml ovid-20230331_def.xml ovid-20230331_lab.xml ovid-20230331_pre.xml ovid2023q1exhibit311.htm ovid2023q1exhibit312.htm ovid2023q1exhibit321.htm ovid-20230331_g1.jpg http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true